No Detail Found!

Clinical characteristics of Mpox at a single center in Saudi Arabia: a retrospective study

Author(s)
Fahad Abuguyan Department of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
Hassan Mohammad Aloraini Department of Emergency Medicine, King Khalid University Hospital, King Saud University Medical City, Riyadh, Saudi Arabia
Alanoud Alessa Department of Emergency Medicine, King Khalid University Hospital, King Saud University Medical City, Riyadh, Saudi Arabia
Tareq Al-Salamah Department of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
Fatimah Alshahrani Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
Lulwah Alabdan Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
Marytonia Valiyaveettil Antony Department of Infection control, King Khalid university hospital, King Saud University Medical City, Riyadh, Saudi Arabia
Abstract
Objectives: To describe the clinical characteristics, treatment and outcomes of Mpox as experienced in a tertiary care center in Riyadh, Saudi Arabia. Methodology: This retrospective study was conducted at King Khalid University Hospital, Riyadh, Saudi Arabia. It included cases seen from May 2022 till the study date. Administrative and electronic medical records were analyzed. Results: Of 33 patients suspected to have Mpox since May 2022, 16 tested positive. In total, 18.8% patients (3/16) had a personal history of recent travel, and 62.5% (10/16) reported some form of recent sexual contact. All the patients presented with rash, and 93.8% had anogenital rash. Mean number of skin lesions was 6.69, and no one had coexisting sexually transmitted diseases. Five (31.25%) received antivirals and no mortality was recorded. Conclusions: All Mpox infections presented with dermatological manifestations. The spread of this disease in our region exhibited some dissimilarities in the clinical presentation and coexisting infections. This highlights the importance of maintaining a high index of suspicion and a low threshold for testing in order to halt further spread.
Publication Details
Page(s) 488-492
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 49, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Saudi Arabia., infectious disease, Monkeypox, Emergency cases
References
Ladnyj ID,Ziegler P,Kima E. .1972 .A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ, 46 : 593-7.
Petersen E,Kantele A,Koopmans M,Asogun D,YinkaOgunleye A,Ihekweazu C .2019 .Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am, 33(4) : 1027-43.
Bunge EM,Hoet B,Chen L,Lienert F,Weidenthaler H,Baer LR .2022 .The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis, 16 : e0010141.
. .. [cited 2023 Nov, 19 : .
Thornhill JP,Barkati S,Walmsley S,Rockstroh J,Antinori A,Harrison LB .2022 .. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. N Engl J Med, 387 : 679-91.
Public ,- June- .2023 .Health Authority SM of H. Interim guidelines for monkeypox V1. -V1, 19 : .
. .Case definitions for use in the 2022 mpox response. Updated 2023 Nov 9; cited 2023 Nov, 19 : .
Cho SY .2022 .The 2022 monkeypox outbreak in nonendemic countries: a review for the emergency department clinician. Clin Exp Emerg Med, 9 : 281-5.
Tarín-Vicente EJ,Alemany A,Agud-Dios M,Ubals M,Suñer C,Antón A .2022 .Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet, 400 : 661-9.
Patel A,Bilinska J,Tam JCH,Da Silva Fontoura D,Mason CY,Daunt A .2022 .Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ, 378 : e072410.
Ogoina D,Iroezindu M,James HI,Oladokun R,YinkaOgunleye A,Wakama P .2020 .Clinical Course and Outcome of Human Monkeypox in Nigeria. Clin Infect Dis, 71 : e210-4.
Zaqout A,Daghfal J,Munir W,Abdelmajid A,Albayat SS,Abukhattab M .2023 .Clinical manifestations and outcome of Mpox infection in Qatar: an observational study during the 2022 outbreak. J Infect Public Health, 16 : 1802-5.
Assiri AM,Al-Tawfiq JA,Jokhdar HA,Algwizani AR,Albarraq AM,Alanazi KH .2023 .Clinical features and outcome of human Mpox (Monkeypox) in Saudi Arabia: an observational study of travel-related cases. J Infect Public Health, 16 : 341-5.
AlBahrani S,AlGarzai R,Aljunaid TO,Al-Tawfiq JA TO .2023 .A case report of mpox (monkeypox) in male traveler. New Microbs New Infect, 53 : 101132.
Multi ,- ,--- .2023 .-country-outbreak-of-mpox-. [cited 2024 Jan, 10 : .
Arabia HIV .2020 .Regional Office for the Eastern Mediterranean. [cited 2024 Jan, 11 : .
0

Citations

0

Downloads

49

Views